EUVIMEDEUVIMED entdecken
Crossref

Hybrid Cell Membrane‐Coated Nanoparticles for Synergizing Sonodynamic Therapy and Immunotherapy against Triple‐Negative Breast Cancer

Jiali Gong, Danling Cheng, Changcun Liu, Shan Wu, Na Sun, Lingzhou Zhao, Jingchao Li iD, Yan Xing, Jinhua Zhao

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202404184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Jiali Gong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Nanoparticles, Immunotherapy, Cell Membrane. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor immunotherapy represents a highly promising modality for the treatment of triple‐negative breast cancer (TNBC). Nevertheless, its therapeutic efficacy has been profoundly impacted by challenges such as low drug uptake, hypoxia, and immunosuppression. To address these problems, the study develops a strategy combining sonodynamic therapy (SDT) and immunotherapy using biomimetic nanoparticles coated with hybrid membranes. The nanoparticles are loaded with semiconducting polymers (PFODBT), Atovaquone (ATO), and TMP195 to enhance biocompatibility, targeting ability, and drug uptake and retention at the tumor site. In in vitro experiments, the biomimetic nanoparticles alleviate hypoxia, induce immunogenic cell death (ICD), and prompt reprogramming of tumor‐associated macrophages (TAMs) from M2 type to M1 type. In in vivo experiments, the synergistic effects of enhanced SDT‐mediated ICD and TAMs repolarization significantly inhibit the proliferation of primary and distant tumor in the 4T1 subcutaneous tumor model, and effectively attenuated metastasis of lung and liver. Moreover, the in vivo immune responses are further activated by improving the maturation of dendritic cells, filtration of CD8 + T cells, and depletion of regulatory T cells. This study offers a novel strategy for TNBC therapy by converting the tumor microenvironment from the “cold” into “hot” tumor through multiple synergistic therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsNanoparticlesImmunotherapyCell MembraneUltrasonic TherapyAnimalsFemaleMiceCell Line, TumorHumansMice, Inbred BALB CTumor Microenvironment

Stichwörter der Autor:innen

immunogenic cell death effectimmunotherapymacrophages repolarizationsonodynamic therapysynergistic therapy

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
  • State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Biological Science and Medical Engineering, Donghua University, Shanghai, 201620, China.
  • Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, 201620, China.

ORCID-Profile: Jingchao Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Gong, J., Cheng, D., Liu, C., Wu, S., Sun, N., Zhao, L., Li, J., Xing, Y., & Zhao, J. (2025). Hybrid Cell Membrane‐Coated Nanoparticles for Synergizing Sonodynamic Therapy and Immunotherapy against Triple‐Negative Breast Cancer. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202404184

Vancouver

Gong J, Cheng D, Liu C, Wu S, Sun N, Zhao L, et al. Hybrid Cell Membrane‐Coated Nanoparticles for Synergizing Sonodynamic Therapy and Immunotherapy against Triple‐Negative Breast Cancer. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202404184

BibTeX
@article{Gong2025,
  author = {Gong, Jiali and Cheng, Danling and Liu, Changcun and Wu, Shan and Sun, Na and Zhao, Lingzhou and Li, Jingchao and Xing, Yan and Zhao, Jinhua},
  title = {Hybrid Cell Membrane‐Coated Nanoparticles for Synergizing Sonodynamic Therapy and Immunotherapy against Triple‐Negative Breast Cancer},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202404184}
}
Kostenlos starten →